Supernus Pharmaceuticals Inc
SUPN
|
|
| |
|
| Trading Volume | 4,673 |
|
|
35.17 - 22.72 |
| Market Cap Full | $ 1.9B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.8% | 17.8% | 1.6% | 9.3% |
| Q2 | - | -20% | -17% | -10.5% |
| Q3 | - | 17.4% | -8.3% | 17.1% |
| Q4 | - | -0.5% | 6.7% | 5.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.8 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -4.4 | 7.3 | 14.8 | -13.6 | -7.8 | -1 | 11 | 17.4 | - | - | - | -1 |
| 2023 | |||||||||||
| 15 | -8.3 | -3.6 | 1.7 | -10.1 | -9.3 | 2.1 | 3.8 | -13.4 | -13.5 | 14.3 | 6.2 |
| 2022 | |||||||||||
| 4.1 | 4.8 | 0.1 | -13.7 | -0.1 | 3.8 | 9.8 | 7.8 | -1.1 | 1.2 | 7.2 | -2.9 |
| 2021 | |||||||||||
| 16.8 | -8 | -2.9 | 15.9 | -0.9 | 2 | -14.5 | 4.6 | -2.3 | 10.9 | 0.4 | -1.3 |
| 2020 | |||||||||||
| -3.4 | -21.8 | - | 30.1 | 3.1 | -1.5 | -6.2 | -1.3 | -5.2 | -11.9 | 17.7 | 16.4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.3 | 0.4 | 0.1 | 0.4 |
| Q2 | -0 | 0.1 | 0.4 | 0.7 |
| Q3 | -0.3 | 0 | 0.4 | 0.7 |
| Q4 | 0 | 0.4 | 0 | 0.6 |
| A | -0.02 | 1 | 1 | 2.4 |